Correlation Between ABVC Biopharma and Anebulo Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both ABVC Biopharma and Anebulo Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ABVC Biopharma and Anebulo Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ABVC Biopharma and Anebulo Pharmaceuticals, you can compare the effects of market volatilities on ABVC Biopharma and Anebulo Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ABVC Biopharma with a short position of Anebulo Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of ABVC Biopharma and Anebulo Pharmaceuticals.
Diversification Opportunities for ABVC Biopharma and Anebulo Pharmaceuticals
0.55 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between ABVC and Anebulo is 0.55. Overlapping area represents the amount of risk that can be diversified away by holding ABVC Biopharma and Anebulo Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Anebulo Pharmaceuticals and ABVC Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ABVC Biopharma are associated (or correlated) with Anebulo Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Anebulo Pharmaceuticals has no effect on the direction of ABVC Biopharma i.e., ABVC Biopharma and Anebulo Pharmaceuticals go up and down completely randomly.
Pair Corralation between ABVC Biopharma and Anebulo Pharmaceuticals
Given the investment horizon of 90 days ABVC Biopharma is expected to generate 0.71 times more return on investment than Anebulo Pharmaceuticals. However, ABVC Biopharma is 1.41 times less risky than Anebulo Pharmaceuticals. It trades about -0.15 of its potential returns per unit of risk. Anebulo Pharmaceuticals is currently generating about -0.19 per unit of risk. If you would invest 63.00 in ABVC Biopharma on September 4, 2024 and sell it today you would lose (9.00) from holding ABVC Biopharma or give up 14.29% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 95.24% |
| Values | Daily Returns |
ABVC Biopharma vs. Anebulo Pharmaceuticals
Performance |
| Timeline |
| ABVC Biopharma |
| Anebulo Pharmaceuticals |
ABVC Biopharma and Anebulo Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with ABVC Biopharma and Anebulo Pharmaceuticals
The main advantage of trading using opposite ABVC Biopharma and Anebulo Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ABVC Biopharma position performs unexpectedly, Anebulo Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Anebulo Pharmaceuticals will offset losses from the drop in Anebulo Pharmaceuticals' long position.| ABVC Biopharma vs. Indaptus Therapeutics | ABVC Biopharma vs. Pasithea Therapeutics Corp | ABVC Biopharma vs. Forte Biosciences | ABVC Biopharma vs. Aileron Therapeutics |
| Anebulo Pharmaceuticals vs. Candel Therapeutics | Anebulo Pharmaceuticals vs. Cingulate Warrants | Anebulo Pharmaceuticals vs. Unicycive Therapeutics | Anebulo Pharmaceuticals vs. Cardio Diagnostics Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Other Complementary Tools
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |